Why cells die and how nearby tissue regrows — insights from fruit flies

Mechanisms and consequences of programmed cell death (apoptosis) and compensatory proliferation in Drosophila

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-11144284

Researchers are using fruit flies to learn how dying cells send signals that make nearby cells multiply, which is important for conditions like cancer, stroke, and neurodegeneration.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-11144284 on NIH RePORTER

What this research studies

This project studies programmed cell death (apoptosis) and a process called apoptosis-induced proliferation (AiP) using genetic and cellular experiments in fruit flies. Scientists will trigger or block cell death in fly tissues, track the signals released by dying cells, and observe how neighboring cells respond at the molecular and tissue level. The team will identify the enzymes and signaling pathways that drive compensatory regrowth and compare findings to results from other animals and human tumor samples when possible. The goal is to define basic biological rules that explain when cell death helps repair tissue or, conversely, fuels tumor regrowth.

Who could benefit from this research

Good fit: People affected by cancer, stroke, or neurodegenerative diseases who want to understand the biological basis of cell loss and tissue repair may find this research relevant to future therapies.

Not a fit: Patients seeking immediate treatments or opportunities to enroll in a clinical trial should not expect direct benefit because the research is basic lab work in fruit flies.

Why it matters

Potential benefit: If successful, the work could point to new targets to promote healthy tissue repair or to prevent tumors from exploiting death-driven regrowth.

How similar studies have performed: Related laboratory studies in flies, frogs, mice, and analyses of human tumors have suggested these death-driven regrowth mechanisms exist, but translation into therapies is still largely unproven.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.